Phase II study of combination chemotherapy of 5-fluorouracil, low-dose leucovorin, and oxaliplatin (FLOX regimen) in pretreated advanced gastric cancer

This phase II study describes the efficacy and safety of combination chemotherapy of 5-fluorouracil (5-FU), low-dose leucovorin, and oxaliplatin (FLOX regimen) for pretreated advanced gastric cancer. Patients who had been previously treated with greater than or equal to one regimen were enrolled. Pa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of oncology 2008-06, Vol.19 (6), p.1135-1140
Hauptverfasser: Jeong, J., Jeung, H.-C., Rha, S.Y., Im, C.K., Shin, S.J., Ahn, J.B., Noh, S.H., Roh, J.K., Chung, H.C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!